Viking Therapeutic (VKTX) Reiterated at Overweight by Cantor Fitzgerald

July 1, 2026 7:03 AM

Cantor Fitzgerald analyst Steven Seedhouse reiterated an Overweight rating and $100.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found